Carmignac has launched its latest fund, Carmignac Portfolio Inflation Solution to investors across Europe. This follows a successful period in the Carmignac Lab, where new products are incubated using internal capital ahead of launch to external clients.
Carmignac Portfolio Inflation Solution aims to deliver a positive return over inflation on a five-year horizon. It intends to offer diversification to traditional allocation in the context of a possible return of a cyclical inflationary regime, driven by evolving demographics, geopolitical and global trade trends. This new macro regime, which the co-fund managers believe started in 2021, is expected to unfold in successive waves and, in their view, should have some material investment and asset allocation consequences. Notably, interest rate-sensitive assets are likely to be intermittently weakened via an expected upward trend in rates over the coming years. The team concludes this environment will call consensus trades into question.
The fund is diversified, investing across asset classes, including commodities, with the aim of outperforming inflation across the cycle. Managed by an experienced team of Carmignac cross-asset fund managers, Frédéric Leroux, Christophe Moulin and Pierre-Edouard Bonenfant, the fund adopts a three-stage investment process.
Firstly, the core multi-asset allocation is constructed to reflect the managers’ strategic vision of the evolving inflation landscape. Secondly, the fund is permanently exposed to future inflation through the use of inflation swaps. Finally, the team manages tactical cross-asset positions to take advantage of short- to medium-term market opportunities. This flexibility allows the managers to soften, amplify or diversify the core portfolio’s performance drivers depending on the position of inflation in its cycle and to enhance return potential. The result is a strategy that is adaptive to a more volatile inflationary environment, alternating between periods of rising prices and disinflation.
Since its launch in the Carmignac Lab in December 2023, the fund has generated a return of 15.27% compared to 3.25% for the reference indicator.1
Frederic Leroux, fund manager and head of cross asset comments:
“After several decades of disinflation, major structural trends that influence long-term prices have simultaneously reversed, ushering in a new era of persistent, cyclical inflation. With a markedly different investment environment, active management with tactical flexibility is required to take advantage and manage the risks of inflation in all phases of its cycle. Carmignac Portfolio Inflation Solution has been designed with precisely this in mind. We prioritise diversification that allows us to challenge the consensus and move away from markets that have long benefited from low inflation towards often neglected markets and assets.”
Carmignac Portfolio Inflation Solution is registered in Austria, Belgium, France, Germany, Italy, Luxembourg, Portugal, Spain and Switzerland.
Articles that may interest you
Carmignac reinforces family anchorage with two board appointments
![[Lettre Edouard Carmignac] [Main media] Edouard Carmignac](https://carmignac.imgix.net/uploads/NextImage/0001/01/a86d5f15d663c68af7c180a5c11c80ff745bece2.jpeg?auto=format%2Ccompress&fit=fill&w=3840)
Edouard Carmignac : A conversation with Thomas Buberl, CEO of AXA
Marketing communication. Please refer to the KID/KIID, prospectus of the fund before making any final investment decisions.
This material may not be reproduced, in whole or in part, without prior authorisation from the Management Company. This material does not constitute a subscription offer, nor does it constitute investment advice. This material is not intended to provide, and should not be relied on for, accounting, legal or tax advice. This material has been provided to you for informational purposes only and may not be relied upon by you in evaluating the merits of investing in any securities or interests referred to herein or for any other purposes. The information contained in this material may be partial information and may be modified without prior notice. They are expressed as of the date of writing and are derived from proprietary and non-proprietary sources deemed by Carmignac to be reliable, are not necessarily all-inclusive and are not guaranteed as to accuracy. As such, no warranty of accuracy or reliability is given and no responsibility arising in any other way for errors and omissions (including responsibility to any person by reason of negligence) is accepted by Carmignac, its officers, employees or agents.
Past performance is not necessarily indicative of future performance. Performances are net of fees (excluding possible entrance fees charged by the distributor). The return may increase or decrease as a result of currency fluctuations, for the shares which are not currency-hedged.
Reference to certain securities and financial instruments is for illustrative purposes to highlight stocks that are or have been included in the portfolios of funds in the Carmignac range. This is not intended to promote direct investment in those instruments, nor does it constitute investment advice. The Management Company is not subject to prohibition on trading in these instruments prior to issuing any communication. The portfolios of Carmignac funds may change without previous notice. The reference to a ranking or prize, is no guarantee of the future results of the UCIS or the manager.
Morningstar Rating™ : © Morningstar, Inc. All Rights Reserved. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
Access to the Funds may be subject to restrictions regarding certain persons or countries. This material is not directed to any person in any jurisdiction where (by reason of that person’s nationality, residence or otherwise) the material or availability of this material is prohibited. Persons in respect of whom such prohibitions apply must not access this material. Taxation depends on the situation of the individual. The Funds are not registered for retail distribution in Asia, in Japan, in North America, nor are they registered in South America. Carmignac Funds are registered in Singapore as restricted foreign scheme (for professional clients only). The Funds have not been registered under the US Securities Act of 1933. The Funds may not be offered or sold, directly or indirectly, for the benefit or on behalf of a «U.S. person», according to the definition of the US Regulation S and FATCA.
The risks, fees and ongoing charges are described in the KID (Key Information Document). The KID must be made available to the subscriber prior to subscription. The subscriber must read the KID. Investors may lose some or all their capital, as the capital in the funds are not guaranteed. The Funds present a risk of loss of capital.
The Funds’ prospectus, KIDs, NAVs and annual reports are available at www.carmignac.com/en, or upon request to the Management Carmignac Portfolio refers to the sub-funds of Carmignac Portfolio SICAV, an investment company under Luxembourg law, conforming to the UCITS Directive. The French investment funds (fonds communs de placement or FCP) are common funds in contractual form conforming to the UCITS or AIFM Directive under French law.
In the United Kingdom: the Funds’ respective prospectuses, KIIDs and annual reports are available at www.carmignac.com/en-gb, or upon request to the Management Company, or for the French Funds, at the offices of the acilities Agent, Carmignac UK Ltd, 2 Carlton House Terrace, London, SW1Y 5AF. This document was prepared by Carmignac Gestion, Carmignac Gestion Luxembourg or Carmignac UK Ltd. FP Carmignac ICVC (the “Company”) is an Investment Company with variable capital incorporated in England and Wales under registered number 839620 and is authorised by the FCA with effect from 4 April 2019 and launched on 15 May 2019. FundRock Partners Limited is the Authorised Corporate Director (the “ACD”) of the Company and is authorised and regulated by the FCA. Registered Office: Hamilton Centre, Rodney Way, Chelmsford, Essex, CM1 3BY, UK; Registered in England and Wales with number 4162989. Carmignac Gestion Luxembourg SA has been appointed as the Investment Manager and distributor in respect of the Company. Carmignac UK Ltd (Registered in England and Wales with number 14162894) has been appointed as a sub-Investment Manager of the Company and is authorised and regulated by the Financial Conduct Authority with FRN:984288.
In Switzerland: the prospectus, KIDs and annual report are available at www.carmignac.com/en-ch, or through our representative in Switzerland, CACEIS (Switzerland), S.A., Route de Signy 35, CH-1260 Nyon. The paying agent is CACEIS Bank, Montrouge, Nyon Branch / Switzerland, Route de Signy 35, 1260 Nyon.
The Management Company can cease promotion in your country anytime. Investors have access to a summary of their rights in English on the following links: UK ; Switzerland ; France ; Luxembourg ; Sweden.
For Carmignac Portfolio Long-Short European Equities: Carmignac Gestion Luxembourg SA in its capacity as the Management Company for Carmignac Portfolio, has delegated the investment management of this Sub-Fund to White Creek Capital LLP (Registered in England and Wales with number OCC447169) from 2nd May 2024. White Creek Capital LLP is authorised and regulated by the Financial Conduct Authority with FRN : 998349.
Carmignac Private Evergreen refers to the Private Evergreen sub-fund of the SICAV Carmignac S.A. SICAV – PART II UCI, registered with the Luxembourg RCS under number B285278.